X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-01 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $24.21 | -40,000 | 2,355,553 | -2% | -$968,231 | ||||||
| M | 2023-02-01 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $24.93 | -40,000 | 2,395,553 | -2% | -$997,210 | |||||
| DM | 2023-01-03 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale+OE | $23.72 | -40,000 | 2,435,553 | -2% | -$948,598 | |||||
2022-12-06 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $27.22 | -40,000 | 2,475,553 | -2% | -$1,088,683 | ||||||
2022-11-01 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $33.51 | -40,000 | 2,515,553 | -2% | -$1,340,387 | ||||||
2022-10-04 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $27.82 | -40,000 | 2,555,553 | -2% | -$1,112,813 | ||||||
2022-09-06 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $14.91 | -40,000 | 2,595,553 | -2% | -$596,274 | ||||||
| M | 2022-08-02 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $18.00 | -40,000 | 2,635,553 | -1% | -$719,835 | |||||
2022-07-07 | INBX | Eckelman Brendan P. | Chief Scientific Officer | S - Sale | $17.17 | -40,000 | 2,675,553 | -1% | -$686,800 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |